Welcome to the MY DIABETES Study!
The MY DIABETES study was set up in 2013 to investigate different types of diabetes in people diagnosed at young age (before the age of 30 years).
MY DIABETES stands for MODY in young-onset diabetes from different ethnicities
We aimed to identify a genetic form of diabetes that is frequently misdiagnosed called, maturity onset diabetes of the young (MODY).
So far we’ve recruited over 1000 individuals and we’re still recruiting.
MY DIABETES
- Latest News
- You may be eligible if...
- What's involved?
- What happens to your samples?
- Recruiting Hospital Sites
We continue to recruit south Asian and African-Caribbean people with diabetes diagnosed under the age of 30 years.
If you think you may be eligible, please contact us.
- Diagnosed with any type of diabetes on the basi of fasting glucose and/or oral glucose tolerance test and/or HbA1c as per WHO criteria.
- Aged below 30 years at diagnosis
- South Asian ancestry - defined as self-reported ancestry and at least 2 grandparents from the Indian Subcontinent (India, Pakistan, Bangladesh or Sri Lanka).
- African and Caribbean ancestry - defined as self-reported ancestry and at least 2 grandparents from the African continent or the Caribbean.
ADULTS
Volunteers will be asked to attend after an overnight fast. During the visit the Research Team will run through the study participant information sheet, answer any questions and, if the participant is happy, document informed consent. The participant will be asked to provide a urine and a blood sample, undergo a general clinical examination and provide a medical history. At the end of the visit usual mediations will be taken and the participant will be sent free to go home and this concludes participation.
CHILDREN
Children participating in the study will attend the research facility with their parent or guardian. They do not need to attend fasting. We’ll ask all of you about the type of diabetes your child has and their treatment. We’ll also ask for a urine test. A small volume of blood will be collected by trained staff for analysis.
The samples will be analysed for antibody positivity, C-peptide levels and other biochemical parameters. Participants will be informed of results via a standardised letter, unless they are antibody negative in which case they will undergo genetic screening for monogenic diabetes. If positive, they will then be informed by the clinical research fellow and given the opportunity to discuss them with a Diabetologist. Please note that genetic testing results can take some time to be disseminated.
Barts
Birmingham
Birmingham Heartlands
Blackburn
Bradford
Bristol
Calderdale and Huddersfield
Central Middlesex
Chorley District
City
Coventry
Ealing
Guy's and St Thomas
Hillingdon
Imperial College
Kings College
Lewisham
Luton and Dunstable
Manchester University
Newham
Northwick Park
Pinderfields
Royal Preston
Russels Hall
Sandwell
Sheffield
St George's
University College Hospital
Walsall Manor
Warwick
West Middlesex
Wolverhampton
Privacy Notice
General Enquiries
Maria Thomas
Project Officer
m.thomas@imperial.ac.uk
Clinical Enquiries
Shivani Misra
Study Lead
s.misra@imperial.ac.uk